Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility StudyLaetitia E. Lamberts, Gooitzen M. van Dam, Vasilis Ntziachristos et al.|Clinical Cancer Research|2016Cited by 289
Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp DetectionJolien J. Tjalma, Wouter B. Nagengast, Vasilis Ntziachristos et al.|Journal of Nuclear Medicine|2015Cited by 70
Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Panagiotis Symvoulidis et al.|Cancer Research|2016Cited by 43
Supplemental Materials and Methods and Supplementary Figures 1 and 2 from Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Unknown|2023Cited by 0
Data from Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast CancerMaximilian Koch, Vasilis Ntziachristos, Johannes S. de Jong et al.|Unknown|2023Cited by 0